Research Department, Instituto de Ojos Oftalmosalud, Lima, Peru.
Cornea. 2012 Jul;31(7):740-5. doi: 10.1097/ICO.0b013e318219aa7a.
To evaluate the safety, efficacy, and stability of sequential corneal collagen cross-linking (CXL) and Ferrara intrastromal corneal ring segment (FR) implantation in selected patients with progressive keratoconus.
This prospective study involved 9 eyes with progressive keratoconus and a preoperative cylinder value equal to or greater than 5 diopters (D) diagnosed between June 2007 and October 2008. Preoperative and postoperative (6 months after the CXL procedure and 6 months after the FR implantation) biomicroscopy examinations, distance uncorrected and best-corrected visual acuities, refractive error, and topographic maps were evaluated and compared.
Mean uncorrected visual acuity was 1.11 logarithm of the minimal angle of resolution (logMAR) preoperatively and 0.75 logMAR at 6 months after CXL (P = 0.03) and 0.23 logMAR at 6 months after FR implantation (P < 0.001). Mean best-corrected visual acuity was 0.26 logMAR preoperatively and 0.24 logMAR at 6 months after CXL (P = 0.87) and 0.12 logMAR at 6 months after FR (P = 0.05). Statistically significant reductions in the mean spherical equivalent (4.38 D; P < 0.001) and mean maximum (5.58 D; P < 0.001) and minimum (4.17 D; P < 0.001) keratometry values were present at 6 months after FR.
FR implantation after CXL is a safe and efficacious treatment option for managing selected patients with progressive keratoconus. Good results in terms of visual acuity, postoperative residual refractive error, and keratometry values were obtained. Longer follow-up would be valuable to confirm the stability of these results.
评估序贯角膜胶原交联(CXL)和 Ferrara 间质角膜环段(FR)植入术治疗进展性圆锥角膜患者的安全性、有效性和稳定性。
本前瞻性研究纳入 2007 年 6 月至 2008 年 10 月诊断为进展性圆锥角膜且术前柱镜值等于或大于 5 屈光度(D)的 9 只眼。评估并比较术前和术后(CXL 术后 6 个月和 FR 植入术后 6 个月)的生物显微镜检查、远距未矫正和最佳矫正视力、屈光不正和地形图。
平均未矫正视力术前为 1.11 最小角分辨率对数(logMAR),CXL 术后 6 个月为 0.75 logMAR(P = 0.03),FR 植入术后 6 个月为 0.23 logMAR(P < 0.001)。平均最佳矫正视力术前为 0.26 logMAR,CXL 术后 6 个月为 0.24 logMAR(P = 0.87),FR 植入术后 6 个月为 0.12 logMAR(P = 0.05)。FR 植入术后 6 个月时,平均等效球镜(4.38 D;P < 0.001)、平均最大(5.58 D;P < 0.001)和最小(4.17 D;P < 0.001)角膜曲率值均显著降低。
CXL 后行 FR 植入术是治疗进展性圆锥角膜患者的一种安全、有效的治疗选择。获得了良好的视力、术后残余屈光不正和角膜曲率值结果。更长时间的随访将有助于确认这些结果的稳定性。